通过多目标路径的De Novo药物设计一致性学习与光束A* 搜索
概括
这项研究引入了一种新的药物发现算法DrugBA,该算法精确优化了最终分子的特性. 药物BA提高了分子生成质量和多样性,优于现有的方法.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 医学中的人工智能
背景情况:
- 药物设计面临的挑战是从广的化学空间中产生高质量的药物样分子.
- 以前用于分子生成的强化学习方法使用了误导性的奖励定义,优化中间步骤而不是最终的分子特性.
- 在之前的算法中将随机性纳入,提高了多样性,但损害了奖励最大化.
研究的目的:
- 开发一种新的算法,DrugBA,用于新的药物设计,可以精确优化最终生成的分子的特性.
- 为了解决以往基于价值的强化学习方法在分子生成中的局限性.
- 提高药物发现产生的分子的质量和多样性.
主要方法:
- 重新定义了即时奖励,将其定义为对最终分子评价得分的改善,专注于最终产品.
- 从A*搜索中使用的路径一致性 (PC) 作为培训价值估计者的目标函数.
- 将价值估计集成到光束搜索决策过程中,以创建DrugBA算法.
主要成果:
- 药物BA能够大规模生成具有高质量和多样性的分子.
- 实验结果显示,在多个分子性质上,与最先进的QADD算法相比,实验结果显著改善.
- 新的奖励定义和路径一致性方法导致更有效的优化.
结论:
- 药物BA算法通过精确优化最终分子特性,在新药设计中取得了重大进展.
- 这种方法有效地平衡了分子质量和多样性,这对于成功的药物发现至关重要.
- 与现有方法相比,DrugBA表现出卓越的性能,为更高效的药物开发管道铺平了道路.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
668
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
668
01:26Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:29Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
44
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
44